- Sparks, A.B., Wang, E.T., Struble, C.A., Barrett, W., et al, Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn (2012), Jan;32(1):3-9.
- Sparks, A.B., Struble, C.A., Wang, E.T., Song, K., Oliphant, A., Non-invasive Prenatal Detection and Selective Analysis of Cell-free DNA Obtained from Maternal Blood: Evaluation for Trisomy 21 and Trisomy 18, Am J Obstet Gynecol. (2012), Apr;206(4):319.e1-9.
- Ashoor, G., Syngelaki, A., Wagner, M., Birdir, C., Nicolaides, K.H., Chromosome-selective sequencing of maternal plasma cell-free DNA for first trimester detection of trisomy 21 and trisomy 18, Am J Obstet Gynecol. (2012), 31(4):237-43. Epub 2012 May 4.
- Ashoor, G., Poon L. Syngelaki, A., Mosimann B, Nicolaides, K.H., Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks’ gestation: effect of maternal and fetal factors, Fetal Diagn Ther. (2012); 31 (4):237-43. Epub 2012 May 4.
- Norton, M., Brar, H., Weiss, J., Karimi, A., et al. Non-Invasive Chromosomal Evaluation (NICE) Study: Results of a Multicenter, Prospective, Cohort Study for Detection of Fetal Trisomy 21 and Trisomy 18, Am J Obstet Gynecol. (2012), Aug;207(2):137.e1-8.
- Norton, M., Brar, H., Weiss, J., Karimi, A., et al. Non-Invasive Chromosomal Evaluation (NICE) Study: Results of a Multicenter, Prospective, Cohort Study for Detection of Fetal Trisomy 21 and Trisomy 18, Am J Obstet Gynecol. (2012), Aug;207(2):137.e1-8.
- Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol. (2012), 207:374.e1-6.
- Ashoor G, Syngelaki A, Nicolaides KH, et al. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method, ULTRASOUND Obstet Gynecol. (2013), Jan;41(1):21-5.
- Song K, Musci T, Caughey A. Clinical Utility and Cost of Non-Invasive Prenatal Testing with cfDNA Analysis in High Risk Women Based on a U.S. Population, J Matern Fetal Neonatal Med. (2013), Aug;26 (12):1180-5.
- Fairbrother, G., Johnson, S., Musci, T. J. and Song, K. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenat. Diagn. (2013), Jun;33(6):580-3.
- Musci, T. J., Fairbrother, G., Batey, A., Bruursema, J., Struble, C. and Song, K. (2013), Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice. Prenat. Diagn. (2013), May;33(5):424-8.
- Gil MD, Quezada MS, Bregnant B, Ferraro M, Nicolaides KH. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies, ULTRASOUND Obstet Gynecol. (2013), Jul;42 (1):34-40.
- Verweij, EJ, Jacobsson B, van Scheltema, PA, et al. European Non-Invasive Trisomy Evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing, Prenat. Diagn. (2013), Jun;33(6):1-6.
- Wang E, Batey A, Struble C, et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn. (2013), Jul;33(7):662-6.
- Gil MD, Quezada MS, Bregant B, Syngelaki A, Nicolaides KH. Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal Diagn Ther. (2013), Nov 15. [Epub ahead of print].
- Struble CA, Syngelaki A, Oliphant A, Song K, Nicolaides, KH. Fetal Fraction Estimate in Twin Pregnancies Using Directed Cell-Free DNA Analysis, Fetal Diagn Ther. (2013), Dec. 7, [Epub aheadof print].